Inventor

VAZQUEZ MICHAEL L

US140 patents

⚠️ This page may combine multiple inventors who share the name “VAZQUEZ MICHAEL L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VAZQUEZ MICHAEL L

SEARLE & CO

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Substituted pyrazoles as p38 kinase inhibitors

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Substituted pyrazoles as p38 kinase inhibitors

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Substituted pyrazoles as p38 kinase inhibitors

Substituted pyrazoles as p38 kinase inhibitors

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

α and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

α-and β-amino acid hydroxyethlamino sulfonamides useful as retroviral protease inhibitors

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Sulfonylalkanoylamino hydroxyethylamimo sulfonamides useful as retroviral protease inhibitors

α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Sulfonylalkanoylamino hydroxyethylamino sulfanamides useful as retroviral protease inhibitors

β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Sulfonylalkanoylamino hydroxyethlamino sulfonamides useful as retroviral protease inhibitors

Phenyl glycines for use in reducing neurotoxic injury

Method for making intermediates useful in the synthesis of retroviral protease inhibitors

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Process for making substituted pyrazoles

Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors

Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

α- and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors

Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors

Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors

Retroviral protease inhibitors

α- and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors

Retroviral protease inhibitors

Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Diacid-containing benzimidazole compounds for treatment of neurotoxic injury

Process for making 5-substituted pyrazoles

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

PHARMACIA CORP

Substituted pyrazoles as p38 kinase inhibitors

(unassigned)

Retroviral protease inhibitors

MONSANTO CO

Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

PFIZER

Pyrrolo[2,3-D]pyrimidine derivatives